A Reappraisal of the Role of Circulating (progenitor) Cells in the Pathobiology of Diabetic Complications

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2013 Nov 1

PMID 24173366

Citations 36

Authors

G P Fadini

Affiliations

Soon will be listed here.

Abstract

Traditionally, the development of diabetic complications has been attributed to the biochemical pathways driving hyperglycaemic cell damage, while reparatory mechanisms have been long overlooked. A more comprehensive view of the balance between damage and repair suggests that an impaired regenerative capacity of bone marrow (BM)-derived cells strongly contributes to defective re-endothelisation and neoangiogenesis in diabetes. Although recent technological advances have redefined the biology and function of endothelial progenitor cells (EPCs), interest in BM-derived vasculotropic cells in the setting of diabetes and its complications remains high. Several circulating cell types of haematopoietic and non-haematopoietic origin are affected by diabetes and are potentially involved in the pathobiology of chronic complications. In addition to classical EPCs, these include circulating (pro-)angiogenic cells, polarised monocytes/macrophages (M1 and M2), myeloid calcifying cells and smooth muscle progenitor cells, having disparate roles in vascular biology. In parallel with the study of elusive progenitor cell phenotypes, it has been recognised that diabetes induces a profound remodelling of the BM stem cell niche. The alteration of circulating (progenitor) cells in the BM is now believed to be the link among distant end-organ complications. The field is rapidly evolving and interest is shifting from specific cell populations to the complex network of interactions that orchestrate trafficking of circulating vasculotropic cells.

Citing Articles

The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)-Rationale and Meta-Analysis of Observational....

Rehak L, Giurato L, Monami M, Meloni M, Scatena A, Panunzi A J Clin Med. 2024; 13(23).

PMID: 39685690 PMC: 11642624. DOI: 10.3390/jcm13237230.

Protective Factors and the Pathogenesis of Complications in Diabetes.

Yu M, Gordin D, Fu J, Park K, Li Q, King G Endocr Rev. 2023; 45(2):227-252.

PMID: 37638875 PMC: 10911956. DOI: 10.1210/endrev/bnad030.

The cardio-renal-metabolic connection: a review of the evidence.

Marassi M, Fadini G Cardiovasc Diabetol. 2023; 22(1):195.

PMID: 37525273 PMC: 10391899. DOI: 10.1186/s12933-023-01937-x.

Downregulated calmodulin expression contributes to endothelial cell impairment in diabetes.

Liu T, Xu H, Liu Z, Zhang H, Zhou H, Zhu Z Acta Pharmacol Sin. 2023; 44(12):2492-2503.

PMID: 37468692 PMC: 10692162. DOI: 10.1038/s41401-023-01127-1.

Assessment of the Relationship Between CD34 Antigen and Vitamin D Level and Insulin Resistance in Patients With Type 2 Diabetes.

Pouresmaeil V, Ebre S, Sarafraz Yazdi M Clin Diabetes. 2022; 40(4):425-433.

PMID: 36385969 PMC: 9606555. DOI: 10.2337/cd21-0091.

References

Fisher S, Doree C, Brunskill S, Mathur A, Martin-Rendon E . Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis. PLoS One. 2013; 8(6):e64669. PMC: 3686792. DOI: 10.1371/journal.pone.0064669. View

Kandala J, Upadhyay G, Pokushalov E, Wu S, Drachman D, Singh J . Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. Am J Cardiol. 2013; 112(2):217-25. DOI: 10.1016/j.amjcard.2013.03.021. View

Masuda H, Iwasaki H, Kawamoto A, Akimaru H, Ishikawa M, Ii M . Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. Stem Cells Transl Med. 2012; 1(2):160-71. PMC: 3659679. DOI: 10.5966/sctm.2011-0023. View

Fadini G, Miorin M, Facco M, Bonamico S, Baesso I, Grego F . Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005; 45(9):1449-57. DOI: 10.1016/j.jacc.2004.11.067. View

Kissa K, Herbomel P . Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature. 2010; 464(7285):112-5. DOI: 10.1038/nature08761. View

Liu X, Li Y, Liu Y, Luo Y, Wang D, Annex B . Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol. 2009; 176(1):504-15. PMC: 2797908. DOI: 10.2353/ajpath.2010.081152. View

Ohtani K, Vlachojannis G, Koyanagi M, Boeckel J, Urbich C, Farcas R . Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells. Circ Res. 2011; 109(11):1219-29. DOI: 10.1161/CIRCRESAHA.111.247304. View

Fadini G, Sartore S, Baesso I, Lenzi M, Agostini C, Tiengo A . Endothelial progenitor cells and the diabetic paradox. Diabetes Care. 2006; 29(3):714-6. DOI: 10.2337/diacare.29.03.06.dc05-1834. View

He T, Smith L, Harrington S, Nath K, Caplice N, Katusic Z . Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke. 2004; 35(10):2378-84. DOI: 10.1161/01.STR.0000141893.33677.5d. View

10.

Fadini G, De Kreutzenberg S, Agostini C, Boscaro E, Tiengo A, Dimmeler S . Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis. 2009; 207(1):213-9. DOI: 10.1016/j.atherosclerosis.2009.03.040. View

11.

Hortenhuber T, Rami-Mehar B, Satler M, Nagl K, Hobaus C, Hollerl F . Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care. 2013; 36(6):1647-53. PMC: 3661838. DOI: 10.2337/dc12-1206. View

12.

Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q . Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009; 114(3):723-32. DOI: 10.1182/blood-2009-02-205930. View

13.

Yu H, Stoneman V, Clarke M, Figg N, Xin H, Kotlikoff M . Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler Thromb Vasc Biol. 2011; 31(6):1291-9. DOI: 10.1161/ATVBAHA.110.218578. View

14.

Albiero M, Rattazzi M, Menegazzo L, Boscaro E, Cappellari R, Pagnin E . Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression. Basic Res Cardiol. 2013; 108(4):368. DOI: 10.1007/s00395-013-0368-7. View

15.

Avogaro A, de Kreutzenberg S, Fadini G . Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract. 2008; 82 Suppl 2:S94-S101. DOI: 10.1016/j.diabres.2008.09.021. View

16.

Tan K, Lessieur E, Cutler A, Nerone P, Vasanji A, Asosingh K . Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy. Exp Eye Res. 2010; 91(2):229-37. PMC: 3895932. DOI: 10.1016/j.exer.2010.05.012. View

17.

Palombo C, Kozakova M, Morizzo C, Gnesi L, Barsotti M, Spontoni P . Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc Diabetol. 2011; 10:88. PMC: 3198903. DOI: 10.1186/1475-2840-10-88. View

18.

Makino H, Okada S, Nagumo A, Sugisawa T, Miyamoto Y, Kishimoto I . Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy. Diabet Med. 2009; 26(2):171-3. DOI: 10.1111/j.1464-5491.2008.02638.x. View

19.

van Ark J, Moser J, Lexis C, Bekkema F, Pop I, van der Horst I . Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. Diabetologia. 2012; 55(9):2501-12. PMC: 3411291. DOI: 10.1007/s00125-012-2590-5. View

20.

Fadini G, Albiero M, Boscaro E, Menegazzo L, Cabrelle A, Piliego T . Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells. Cell Biol Int. 2010; 34(7):709-15. DOI: 10.1042/CBI20090473. View